SYNTARA LIMITEDSYNTARA LIMITEDSYNTARA LIMITED

SYNTARA LIMITED

No trades
See on Supercharts

SNT fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Syntara Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. Its respiratory products include bronchitol and aridol. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
SNT has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company